tiprankstipranks
Propanc Biopharma (PPCB)
NASDAQ:PPCB
US Market
PPCB
Propanc Biopharma
RESEARCH TOOLSreports
Want to see PPCB full AI Analyst Report?

Propanc Biopharma (PPCB) Income Statement

80 Followers

Propanc Biopharma Income Statement

Last quarter (Q3 2026), Propanc Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Propanc Biopharma's net income was $-6.36M. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -21.66K$ -17.76K$ -5.67K$ 0.00
Operating Expenses
$ 57.28M$ 1.51M$ 1.76M$ 1.99M$ 1.81M
Depreciation and Amortization
$ 20.19K$ 21.66K$ 22.93K$ 1.99K$ 1.99K
EBITDA
$ -58.34M$ -1.26M$ -2.23M$ -2.14M$ -1.69M
Operating Income
$ -57.28M$ -1.54M$ -1.78M$ -1.99M$ -1.81M
Other Income/Expenses
$ -1.65M$ -414.00K$ -1.01M$ -722.00K$ -327.00K
Pretax Income
$ -58.92M$ -1.95M$ -2.79M$ -2.71M$ -2.14M
Net Income
$ -58.92M$ -1.82M$ -2.66M$ -2.66M$ -2.03M
Per Share Metrics
Basic EPS
$ -371.25$ -35.52K$ -781.71K$ -27.99M$ -20.00K
Diluted EPS
$ -371.25$ -30.00K$ -781.71K$ -27.99M$ -20.00K
Weighted Average Shares Outstanding
-- 4.00--
Weighted Average Shares Outstanding (Diluted)
-- 4.00--
Currency in USD

Propanc Biopharma Earnings and Revenue History